You can buy or sell MRNS and other stocks, options, ETFs, and crypto commission-free!
Marinus Pharmaceuticals, Inc. Common Stock, also called Marinus Pharmaceuticals, is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Read More Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA. The listed name for MRNS is Marinus Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 4